In immunocompromised individuals,<unk>  has been associated with fungemia or localized infection, which may be fatal. Overall,<unk>  is safe for use in otherwise healthy populations and fungemia with<unk>  has not been reported, to the best of the recent evidences in immunocompetent patients. A review of HIV-1-infected patients given therapy with<unk>  indicated it was safe. A retrospective study on 32,000 oncohematological hospitalized patients showed no occurrence of fungal sepsis with<unk>  use.
Saccharomyces boulardii
Candida tropicalis
Candida dubliniensis
Actinomyces naeslundii
Candida parapsilosis
Candida krusei
Aspergillus tubingensis
Talaromyces marneffei